Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v36-FR Version v33-EN
Language French English
Date Updated 2019-11-05 2019-10-23
Drug Identification Number 02299194 02299194
Brand name RALIVIA RALIVIA
Common or Proper name RALIVIA RALIVIA
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients TRAMADOL HYDROCHLORIDE TRAMADOL HYDROCHLORIDE
Strength(s) 100MG 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 90 90
ATC code N02AX N02AX
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-18 2019-03-18
Estimated end date 2019-10-29
Actual end date 2019-10-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments